Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Navigation apparatus, search result display method, and graphical user interface
Implementing state-of-the-art gate transistor, sidewall profile/angle control by tuning gate etch process recipe parameters
Method of manufacturing touch panel
Method and apparatus for supporting management actions for very high throughput in wireless communications
Variants of a family 44 xyloglucanase
Method for detecting motion of an electrical device or apparatus
Method and system for cooling of integrated circuits
  Randomly Featured Patents
Noise filter for video processing
Method of protecting aluminum nitride circuit substrates during electroless plating using sol-gel oxide films and article made therefrom
Trailer hitch assembly
Percussion drilling apparatus
Biocompatible polyacrylate compositions for medical applications
Utility waistbelt
Ring signal discriminator
Cleaning device
Swivel adapter for faucets
Screening system for objects in transit